131 related articles for article (PubMed ID: 14563441)
1. Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula.
Sniderman AD; Blank D; Zakarian R; Bergeron J; Frohlich J
Clin Biochem; 2003 Oct; 36(7):499-504. PubMed ID: 14563441
[No Abstract] [Full Text] [Related]
2. On the presumed inaccuracy of the Friedewald formula in hypertriglyceridemic plasma: a role for imprecise analysis?
Demacker PN; Toenhake-Dijkstra H; de Rijke YB; Stalenhoef AF; Stuyt PM; Willems HL
Clin Chem; 1996 Sep; 42(9):1491-4. PubMed ID: 8787712
[No Abstract] [Full Text] [Related]
3. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications.
Martin SS; Blaha MJ; Elshazly MB; Brinton EA; Toth PP; McEvoy JW; Joshi PH; Kulkarni KR; Mize PD; Kwiterovich PO; Defilippis AP; Blumenthal RS; Jones SR
J Am Coll Cardiol; 2013 Aug; 62(8):732-9. PubMed ID: 23524048
[TBL] [Abstract][Full Text] [Related]
4. New Sampson Low-Density Lipoprotein Equation: Better Than Friedewald and Martin-Hopkins.
Koch CD; El-Khoury JM
Clin Chem; 2020 Aug; 66(8):1120-1121. PubMed ID: 32746460
[No Abstract] [Full Text] [Related]
5. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
Frost PH; Havel RJ
Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
[TBL] [Abstract][Full Text] [Related]
6. Serum lipids and apolipoproteins in children with the Smith-Lemli-Opitz syndrome.
Behúlová D; Bzdúch V; Skodová J; Dello Russo A; Corso G; Ponec J; Kasanická A
J Inherit Metab Dis; 2000 Jun; 23(4):413-5. PubMed ID: 10896307
[No Abstract] [Full Text] [Related]
7. Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Korean Adults: Findings from the Korea National Health and Nutrition Examination Survey, 2009-2011.
Lee J; Jang S; Son H
PLoS One; 2016; 11(1):e0148147. PubMed ID: 26824910
[TBL] [Abstract][Full Text] [Related]
8. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
[No Abstract] [Full Text] [Related]
9. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein profiling by high performance gel chromatography.
Tallis GA; Shephard MD; Whiting MJ
Clin Chim Acta; 1994 Aug; 228(2):171-9. PubMed ID: 7988033
[TBL] [Abstract][Full Text] [Related]
11. Serum apolipoprotein AI, B, and lipoprotein (a) levels in hypercholesterolemic schoolchildren.
Uslu S; Uçar B; Colak O; Alatas O; Kiliç Z
Clin Biochem; 1999 Aug; 32(6):495-7. PubMed ID: 10667490
[No Abstract] [Full Text] [Related]
12. Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels.
Bairaktari E; Hatzidimou K; Tzallas C; Vini M; Katsaraki A; Tselepis A; Elisaf M; Tsolas O
Clin Biochem; 2000 Oct; 33(7):549-55. PubMed ID: 11124340
[TBL] [Abstract][Full Text] [Related]
13. Low-Density Lipoprotein Measurement Discordance: When 2 Wrongs Lead to the Right Answer-Elevated Lipoprotein (a).
Intwala S; Stone NJ; Balady GJ
JAMA Cardiol; 2017 Jun; 2(6):697-698. PubMed ID: 28355452
[No Abstract] [Full Text] [Related]
14. Plasma vitamin E, apolipoprotein B and HDL-cholesterol in middle-aged men from southern Italy.
Rubba P; Mancini M; Fidanza F; Leccia G; Riemersma RA; Gey KF
Atherosclerosis; 1989 May; 77(1):25-9. PubMed ID: 2719759
[TBL] [Abstract][Full Text] [Related]
15. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints.
Warnick GR; Knopp RH; Fitzpatrick V; Branson L
Clin Chem; 1990 Jan; 36(1):15-9. PubMed ID: 2297909
[TBL] [Abstract][Full Text] [Related]
16. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
[TBL] [Abstract][Full Text] [Related]
17. Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease.
Matas C; Cabré M; La Ville A; Prats E; Joven J; Turner PR; Masana L; Camps J
Clin Chem; 1994 Mar; 40(3):404-6. PubMed ID: 8131276
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.
Whelton SP; Meeusen JW; Donato LJ; Jaffe AS; Saenger A; Sokoll LJ; Blumenthal RS; Jones SR; Martin SS
J Clin Lipidol; 2017; 11(4):1065-1072. PubMed ID: 28826567
[TBL] [Abstract][Full Text] [Related]
19. Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P?
Master SR; Rader DJ
Clin Chem; 2013 May; 59(5):723-5. PubMed ID: 23487171
[No Abstract] [Full Text] [Related]
20. The Friedewald formula: statistical acrobatics?
Lippi U; Graziani MS; Manzato F; Schinella M
Clin Chem; 1986 May; 32(5):909-11. PubMed ID: 3457655
[No Abstract] [Full Text] [Related]
[Next] [New Search]
